BFM
MRTX

Boothbay Fund Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Boothbay Fund Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,000
Closed -$470K – 2063
2023
Q4 		$470K Buy
+8,000
New +$450K 0.01% 1009
2021
Q2 		– Sell
-187
Closed -$3.2M – 2197
2021
Q1 		$3.2M Buy
+187
New +$37K 0.12% 188
2020
Q4 		– Sell
-634
Closed -$10.5M – 1474
2020
Q3 		$10.5M Buy
634
+445
+235% +$60.9K 0.64% 16
2020
Q2 		$2.16M Sell
189
-27
-13% -$2.62K 0.15% 179
2020
Q1 		$1.66M Buy
216
+134
+163% +$12K 0.14% 184
2019
Q4 		$1.06M Sell
82
-110
-57% -$10.6K 0.09% 303
2019
Q3 		$1.5M Buy
+192
New +$18K 0.14% 208
2019
Q2 		– Sell
-196
Closed -$1.44M – 937
2019
Q1 		$1.44M Buy
+196
New +$13.3K 0.14% 165

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boothbay Fund Management's MRTX Position: Q1 2024 in Review

Boothbay Fund Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 10,000 shares — an estimated $588K sold.

Boothbay Fund Management first reported a position in MRTX in Q3 2020 and held it in 4 quarters. The position peaked at $917K in Q4 2022. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Boothbay Fund Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 10,000 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $588K.
  • Boothbay Fund Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Boothbay Fund Management's Mirati Therapeutics, Inc. Common Stock position peaked at $917K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.